BIOMAT Database Logo BIOMAT Database Logo

[Neonatal hyperthyroidism. Report of a patient born from a mother with recurrent Graves-Basedow disease (author's transl)]. 1979

M Alger, and A García-Herrera, and S Castillo, and J E Ruíz, and E S Canales, and A Zárate

UI MeSH Term Description Entries
D006980 Hyperthyroidism Hypersecretion of THYROID HORMONES from the THYROID GLAND. Elevated levels of thyroid hormones increase BASAL METABOLIC RATE. Hyperthyroid,Primary Hyperthyroidism,Hyperthyroidism, Primary,Hyperthyroids
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D007232 Infant, Newborn, Diseases Diseases of newborn infants present at birth (congenital) or developing within the first month of birth. It does not include hereditary diseases not manifesting at birth or within the first 30 days of life nor does it include inborn errors of metabolism. Both HEREDITARY DISEASES and METABOLISM, INBORN ERRORS are available as general concepts. Neonatal Diseases,Disease, Neonatal,Diseases, Neonatal,Neonatal Disease
D008431 Maternal-Fetal Exchange Exchange of substances between the maternal blood and the fetal blood at the PLACENTA via PLACENTAL CIRCULATION. The placental barrier excludes microbial or viral transmission. Transplacental Exposure,Exchange, Maternal-Fetal,Exposure, Transplacental,Maternal Fetal Exchange
D008713 Methimazole A thioureylene antithyroid agent that inhibits the formation of thyroid hormones by interfering with the incorporation of iodine into tyrosyl residues of thyroglobulin. This is done by interfering with the oxidation of iodide ion and iodotyrosyl groups through inhibition of the peroxidase enzyme. Methymazol,Thiamazole,1-Methyl-2-mercaptoimidazole,Favistan,Mercasolyl,Mercazol,Mercazole,Mercazolyl,Merkazolil,Methizol,Methylmercaptoimidazole,Metisol,Metizol,Strumazol,Tapazole,Thiamazol Henning,Thiamazol Hexal,Thimazol,Thyrozol,Tiamazol,Tirodril,1 Methyl 2 mercaptoimidazole,Henning, Thiamazol,Hexal, Thiamazol
D011188 Potassium An element in the alkali group of metals with an atomic symbol K, atomic number 19, and atomic weight 39.10. It is the chief cation in the intracellular fluid of muscle and other cells. Potassium ion is a strong electrolyte that plays a significant role in the regulation of fluid volume and maintenance of the WATER-ELECTROLYTE BALANCE.
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D012008 Recurrence The return of a sign, symptom, or disease after a remission. Recrudescence,Relapse,Recrudescences,Recurrences,Relapses
D005260 Female Females
D006111 Graves Disease A common form of hyperthyroidism with a diffuse hyperplastic GOITER. It is an autoimmune disorder that produces antibodies against the THYROID STIMULATING HORMONE RECEPTOR. These autoantibodies activate the TSH receptor, thereby stimulating the THYROID GLAND and hypersecretion of THYROID HORMONES. These autoantibodies can also affect the eyes (GRAVES OPHTHALMOPATHY) and the skin (Graves dermopathy). Basedow's Disease,Exophthalmic Goiter,Goiter, Exophthalmic,Graves' Disease,Basedow Disease,Hyperthyroidism, Autoimmune,Basedows Disease,Disease, Basedow,Disease, Basedow's,Disease, Graves,Disease, Graves',Exophthalmic Goiters,Goiters, Exophthalmic

Related Publications

M Alger, and A García-Herrera, and S Castillo, and J E Ruíz, and E S Canales, and A Zárate
Neonatal hyperthyroidism: neonatal clinical course of two brothers born to a mother with Graves-Basedow disease, before and after total thyroidectomy.
April 2007, Journal of pediatric endocrinology & metabolism : JPEM,
M Alger, and A García-Herrera, and S Castillo, and J E Ruíz, and E S Canales, and A Zárate
[Treatment of the hyperthyroidism of Graves-Basedow disease with thiocarbamides (author's transl)].
January 1977, Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion,
M Alger, and A García-Herrera, and S Castillo, and J E Ruíz, and E S Canales, and A Zárate
[Basedow-Graves' disease: operative treatment (author's transl)].
November 1978, Langenbecks Archiv fur Chirurgie,
M Alger, and A García-Herrera, and S Castillo, and J E Ruíz, and E S Canales, and A Zárate
Different fetal-neonatal outcomes in siblings born to a mother with Graves-Basedow disease after total thyroidectomy: a case series.
February 2010, Journal of medical case reports,
M Alger, and A García-Herrera, and S Castillo, and J E Ruíz, and E S Canales, and A Zárate
[Case of apathetic form of Graves-Basedow disease with hyperthyroidism].
August 1973, Wiadomosci lekarskie (Warsaw, Poland : 1960),
M Alger, and A García-Herrera, and S Castillo, and J E Ruíz, and E S Canales, and A Zárate
Fetal Hyperthyroidism Secondary to Maternal Basedow-Graves' Disease.
April 2024, AJP reports,
M Alger, and A García-Herrera, and S Castillo, and J E Ruíz, and E S Canales, and A Zárate
Prediction of neonatal hyperthyroidism in infants born to mothers with Graves disease.
February 1996, The Journal of pediatrics,
M Alger, and A García-Herrera, and S Castillo, and J E Ruíz, and E S Canales, and A Zárate
[Neonatal hyperthyroidism in a premature infant born to a mother with Grave's disease].
May 2000, Archives de pediatrie : organe officiel de la Societe francaise de pediatrie,
M Alger, and A García-Herrera, and S Castillo, and J E Ruíz, and E S Canales, and A Zárate
[Characteristics of neuromuscular symptoms in patients with Graves-Basedow disease in hyperthyroidism].
September 1987, Polski tygodnik lekarski (Warsaw, Poland : 1960),
M Alger, and A García-Herrera, and S Castillo, and J E Ruíz, and E S Canales, and A Zárate
Neurodevelopmental follow-up of children born to mothers with Graves' disease and neonatal hyperthyroidism.
May 2024, Hormone research in paediatrics,
Copied contents to your clipboard!